These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 11103056)
1. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Cheng CH; Sanders GD; Hlatky MA; Heidenreich P; McDonald KM; Lee BK; Larson MS; Owens DK Ann Intern Med; 2000 Dec; 133(11):864-76. PubMed ID: 11103056 [TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of radiofrequency catheter ablation versus medical treatment for paroxysmal supraventricular tachycardia in Japan. Ikeda T; Sugi K; Enjoji Y; Kasao M; Abe R; Ninomiya K; Yabuki S; Yamaguchi T J Cardiol; 1994; 24(6):461-8. PubMed ID: 7823285 [TBL] [Abstract][Full Text] [Related]
3. Radiofrequency catheter ablation of supraventricular tachycardia in children and adolescents : feasibility and cost-effectiveness in a low-income country. Vida VL; Calvimontes GS; Macs MO; Aparicio P; Barnoya J; Castañeda AR Pediatr Cardiol; 2006; 27(4):434-9. PubMed ID: 16830085 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of ablation of ventricular tachycardia in ischaemic cardiomyopathy: limitations in the trial evidence base. Chen Y; Gomes M; Garcia JV; Hunter RJ; Chow AW; Dhinoja M; Schilling RJ; Lowe M; Lambiase PD Open Heart; 2020; 7(1):e001155. PubMed ID: 32076562 [TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of radiofrequency catheter ablation in the treatment of symptomatic supraventricular tachyarrhythmias. Kertes PJ; Kalman JM; Tonkin AM Aust N Z J Med; 1993 Aug; 23(4):433-6. PubMed ID: 8240167 [TBL] [Abstract][Full Text] [Related]
6. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Bathina MN; Mickelsen S; Brooks C; Jaramillo J; Hepton T; Kusumoto FM Am J Cardiol; 1998 Sep; 82(5):589-93. PubMed ID: 9732885 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Reynolds MR; Zimetbaum P; Josephson ME; Ellis E; Danilov T; Cohen DJ Circ Arrhythm Electrophysiol; 2009 Aug; 2(4):362-9. PubMed ID: 19808491 [TBL] [Abstract][Full Text] [Related]
8. Should radiofrequency therapy be performed in every symptomatic patient with supraventricular tachycardia? (Pro drug position). Andresen D; Behrens S; Brüggemann T; Schröder R Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 2):653-7. PubMed ID: 7681971 [TBL] [Abstract][Full Text] [Related]
9. Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction. Chew DS; Loring Z; Anand J; Fudim M; Lowenstern A; Rymer JA; Weimer KED; Atwater BD; DeVore AD; Exner DV; Noseworthy PA; Yancy CW; Mark DB; Piccini JP Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e007094. PubMed ID: 33280436 [TBL] [Abstract][Full Text] [Related]
11. Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure. Gao L; Moodie M BMJ Open; 2019 Sep; 9(9):e031033. PubMed ID: 31492790 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy). Goldberg AS; Bathina MN; Mickelsen S; Nawman R; West G; Kusumoto FM Am J Cardiol; 2002 May; 89(9):1120-3. PubMed ID: 11988206 [No Abstract] [Full Text] [Related]
13. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation. Lau D; Sandhu RK; Andrade JG; Ezekowitz J; So H; Klarenbach S J Am Heart Assoc; 2021 Jul; 10(14):e019599. PubMed ID: 34238020 [TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy. Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739 [TBL] [Abstract][Full Text] [Related]
15. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study. Pappone C; Vicedomini G; Augello G; Manguso F; Saviano M; Baldi M; Petretta A; Giannelli L; Calovic Z; Guluta V; Tavazzi L; Santinelli V Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):808-14. PubMed ID: 21946315 [TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Cryoballoon Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation in China: Results Based on Real-World Data. Ming J; Wei Y; Sun H; Wong G; Yang G; Pong R; Chen Y Value Health; 2019 Aug; 22(8):863-870. PubMed ID: 31426926 [TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of treatment of supraventricular arrhythmias related to an accessory atrioventricular pathway: comparison of catheter ablation, surgical division and medical treatment. Weerasooriya HR; Murdock CJ; Harris AH; Davis MJ Aust N Z J Med; 1994 Apr; 24(2):161-7. PubMed ID: 8042944 [TBL] [Abstract][Full Text] [Related]
19. A Long-Term Cost-Effectiveness Analysis Comparing Radiofrequency Catheter Ablation with Antiarrhythmic Drugs in Treatment of Chinese Patients with Atrial Fibrillation. Du X; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Yin H; Xuan J; Dong J; Ma C Am J Cardiovasc Drugs; 2019 Dec; 19(6):569-577. PubMed ID: 31090018 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome. Hogenhuis W; Stevens SK; Wang P; Wong JB; Manolis AS; Estes NA; Pauker SG Circulation; 1993 Nov; 88(5 Pt 2):II437-46. PubMed ID: 8222191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]